Our unique two-part formulation ensures freshness and efficacy
Novo Nordisk will almost certainly launch with: A savings card for patients with commercial insurance (reducing costs to $25$50/month in many cases) A patient assistance program for income-qualifying uninsured patients Possible direct-to-consumer pricing through NovoCare Pharmacy, similar to Wegovys $349/month self-pay model
Many people notice periods of fatigue as their body adjusts to weight loss, changes in appetite, and new routines
I., Haber, M., Henderson, M
Compared to adults without diabetes, those with diabetes have a much higher risk of developing cardiovascular disease, with the risk increasing as blood sugar levels rise [3]
Both Victoza and Saxenda are self-injected once daily using a prefilled pen